Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
State boards and NABP pilot Pulse to detect counterfeit meds as DSCSA deadlines approach
Summary
Josh Bolan of the National Association of Boards of Pharmacy described a DSCSA‑compliant digital directory, Pulse, and said early scans using the tool helped identify illegitimate GLP‑1 products. The subcommittee heard that improved electronic tracing and state use of Pulse can reduce counterfeit entries and help manage shortages.
The National Association of Boards of Pharmacy told a House subcommittee that new digital tools tied to the Drug Supply Chain Security Act (DSCSA) are beginning to give regulators and trading partners better visibility into the U.S. pharmaceutical supply chain and have already helped identify illegitimate and counterfeit products in the field.
Josh Bolan of NABP described Pulse, a DSCSA‑aligned platform launched in January that acts as a directory of manufacturers, distributors and pharmacies and enables scanning…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
